Cargando…

Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review

Background: Radiotherapy is a mainstay in head and neck squamous cell carcinoma (HNSCC) treatment but is mostly applied without stratification by molecular diagnostics. Development of reliable biomarkers may have the potential to improve radiotherapy (RT) efficacy and reduce toxicity. We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schanne, Daniel H., Koch, Alexander, Elicin, Olgun, Giger, Roland, Medová, Michaela, Zimmer, Yitzhak, Aebersold, Daniel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775486/ https://www.ncbi.nlm.nih.gov/pubmed/36552043 http://dx.doi.org/10.3390/biomedicines10123288

Ejemplares similares

Profiling Invasiveness in Head and Neck Cancer: Recent Contributions of Genomic and Transcriptomic Approaches
por: Nisa, Lluís, et al.
Publicado: (2015)

Stereotactic body radiotherapy for recurrent hemoptysis due to chronic pulmonary aspergillosis: a case report and systematic review of the literature
por: Koch, Alexander, et al.
Publicado: (2022)

Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy
por: Bojaxhiu, Beat, et al.
Publicado: (2020)

Impact of pretreatment second look (18)FDG-PET/CT on stage and treatment changes in head and neck cancer
por: Elicin, Olgun, et al.
Publicado: (2021)

The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
por: Medová, Michaela, et al.
Publicado: (2013)

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
por: Bojaxhiu, Beat, et al.
Publicado: (2018)

Superior loco-regional control after primary surgery compared to chemo-radiotherapy for advanced stage laryngeal cancer
por: Shelan, Mohamed, et al.
Publicado: (2023)

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
por: Poliaková, Michaela, et al.
Publicado: (2018)

PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
por: Nisa, Lluís, et al.
Publicado: (2017)

CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
por: Hovhannisyan, Lusine, et al.
Publicado: (2023)

Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome
por: Elicin, Olgun, et al.
Publicado: (2020)

Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg?
por: Elicin, Olgun, et al.
Publicado: (2017)

Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases
por: Bertholet, Jenny, et al.
Publicado: (2022)

Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer
por: Bojaxhiu, Beat, et al.
Publicado: (2022)

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 1 (Head and Neck Surgery)
por: Dulguerov, Pavel, et al.
Publicado: (2019)

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 4 (Biomarkers)
por: Broglie, Martina A., et al.
Publicado: (2019)

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer
por: Piguet, Anne-Christine, et al.
Publicado: (2015)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

A Comparative Analysis of Individual RAS Mutations in Cancer Biology
por: Muñoz-Maldonado, Carmen, et al.
Publicado: (2019)

Implementation and experimental validation of a robust hybrid direct aperture optimization approach for mixed‐beam radiotherapy
por: Heath, Emily, et al.
Publicado: (2021)

Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
por: Bensimon, Ariel, et al.
Publicado: (2020)

Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome
por: Anschuetz, Lukas, et al.
Publicado: (2023)

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 2 (Radiation Oncology)
por: Elicin, Olgun, et al.
Publicado: (2019)

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 3 (Medical Oncology)
por: Siano, Marco, et al.
Publicado: (2019)

Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2022)

A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response
por: Koch, Jonas P., et al.
Publicado: (2023)

An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2022)

Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2023)

Long-term functional outcome after laryngeal cancer treatment
por: Anschuetz, Lukas, et al.
Publicado: (2019)

A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need
por: Filippini, Daria Maria, et al.
Publicado: (2023)

ProtRank: bypassing the imputation of missing values in differential expression analysis of proteomic data
por: Medo, Matúš, et al.
Publicado: (2019)

Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury
por: Melin, Nicolas, et al.
Publicado: (2021)

Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data
por: Mei, Mei, et al.
Publicado: (2020)

Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
por: Elicin, Olgun, et al.
Publicado: (2019)

Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Borsetto, Daniele, et al.
Publicado: (2021)

The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2022)

Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review
por: Mariani, Marco, et al.
Publicado: (2021)

Precision Medicine on the Effects of Microbiota on Head–Neck Diseases and Biomarkers Diagnosis
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023)

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients
por: Brøndum, Line, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c36lt5jdns1onipq9r9rpt7p05